Thrombin specificity
- PMID: 8578445
Thrombin specificity
Abstract
A model of thrombin interaction with distinct substrates or ligands has been derived from the crystallographic studies of thrombin-inhibitors complexes, and buttressed by functional studies with mutant thrombins, thrombin proteolytic derivatives or antibodies against thrombin. The unique specificity of thrombin for its substrates and ligands may be ascribed to multiple interactions with both the active site cleft and exosite(s) distinct from the active site. Two prominent insertion loops around Trp 50 and Trp 148 project over the active site cleft and play an important role in the substrates selection. Several substrates (fibrinogen, thrombin receptor, heparin cofactor II) or ligands (thrombomodulin, glycoprotein Ib) interact with a large exosite located on the surface of the loop segment 65-76, mainly constituted of basic amino acids, designated anion binding exosite 1. Interaction with these various macromolecules appears to involve a limited number of residues within the large exosite 1. It is conceivable that exosite 1 contains distinct subsites, although most of them may overlap. A second basic exosite (anion binding exosite 2) is located close to the carboxy-terminal B chain helix. Exosite 2 interacts with heparin, the chondroitin sulfate moiety of thrombomodulin and prothrombin activation fragment 2. Interaction of ligands with either exosite 1 or exosite 2 leads to conformational changes of the thrombin molecule, that may be important determinants of thrombin specificity. Whether exosite 2 cooperates with exosite 1 for thrombin interaction with fibrin(ogen) or the thrombin receptor remains to be determined.
Similar articles
-
The effects of exosite occupancy on the substrate specificity of thrombin.Arch Biochem Biophys. 2009 Sep;489(1-2):48-54. doi: 10.1016/j.abb.2009.07.012. Epub 2009 Jul 26. Arch Biochem Biophys. 2009. PMID: 19638274
-
Energetics of thrombin-thrombomodulin interaction.Biochemistry. 1997 Jun 3;36(22):6674-81. doi: 10.1021/bi962766a. Biochemistry. 1997. PMID: 9184147
-
Conformational analysis of gamma' peptide (410-427) interactions with thrombin anion binding exosite II.Biochemistry. 2006 Jun 20;45(24):7434-45. doi: 10.1021/bi060360k. Biochemistry. 2006. PMID: 16768439
-
Synthetic peptides and peptidomimetics as substrates and inhibitors of thrombin and other proteases in the blood coagulation system.Blood Coagul Fibrinolysis. 1994 Jun;5(3):411-36. Blood Coagul Fibrinolysis. 1994. PMID: 8075312 Review.
-
Molecular Interactions of Thrombin.Semin Thromb Hemost. 1996;22(2):117-24. doi: 10.1055/s-2007-998998. Semin Thromb Hemost. 1996. PMID: 8807707 Review.
Cited by
-
Structures of liganded glycosylphosphatidylinositol transamidase illuminate GPI-AP biogenesis.Nat Commun. 2023 Sep 8;14(1):5520. doi: 10.1038/s41467-023-41281-y. Nat Commun. 2023. PMID: 37684232 Free PMC article.
-
Thrombin inhibitors from different animals.J Biomed Biotechnol. 2010;2010:641025. doi: 10.1155/2010/641025. Epub 2010 Oct 4. J Biomed Biotechnol. 2010. PMID: 20976270 Free PMC article. Review.
-
Engineering a protease-based and site-specific PEGylation-based strategy for the controlled release of exenatide.RSC Adv. 2020 Jun 30;10(42):25013-25021. doi: 10.1039/d0ra01010c. eCollection 2020 Jun 29. RSC Adv. 2020. PMID: 35517470 Free PMC article.
-
Molecular and functional diversity of vascular endothelial growth factors.Mol Divers. 2006 Nov;10(4):515-27. doi: 10.1007/s11030-006-9027-3. Mol Divers. 2006. PMID: 16972015 Review.
-
Hyperproduction of fibrin and inefficacy of antithrombin III and alpha2 macroglobulin in the presence of bacterial porins.Int J Exp Pathol. 2005 Aug;86(4):241-5. doi: 10.1111/j.0959-9673.2005.00430.x. Int J Exp Pathol. 2005. PMID: 16045546 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources